| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Knell Michael Gunnar | CSVP, CAO, Interim CFO | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Michael G. Knell | 02 Feb 2026 | 0001543779 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $0 | +1,668 | +12% | $0.000000 | 15,128 | 30 Jan 2026 | Direct | F1 |
| transaction | CRL | Common Stock | Tax liability | $111,344 | -526 | -3.5% | $211.68 | 14,602 | 30 Jan 2026 | Direct |
| Id | Content |
|---|---|
| F1 | Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. |